Functional genomics company
Enhanc3D Genomics has raised €11M across 1 funding round from 3 investors, most recently a Series A round in Oct 2022. Based in Cambridge, UK; active in Deeptech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-20 | Series A | €11M |
| BGF,Bioqube Ventures,Parkwalk Advisors |
| View deal → |
